Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
Rapid changes in the pharmaceutical and drug development fields require a dedicated team of experts. Our consulting experience includes applying actuarial principles to health economics challenges for both pharmaceuticals and medical devices and builds on the support of in-house health economists and clinicians. Our areas of research draw on real-world evidence and outcomes data.
In collaboration with the National Institute for Health and Care Excellence (NICE) in England, we explore some alternative methodological approaches that build on the incremental cost-effectiveness ratio.
We explore how the principles of insurance can be applied to structure reimbursement models for novel antibiotics, and ultimately stimulate innovation while offering financial protection to payers.
A research report that evaluates alternative payment models that potentially could be instituted by healthcare payers and manufacturers to pay for high-cost curative disease therapies and prescription drugs.
The rapid uptake of genetic testing within the National Health Service (NHS) and current debate around genetics make evaluating tailored interventions increasingly more relevant to ensure an efficient use of NHS spend.
The National Institute for Health and Clinical Excellence in England offers an interesting model for healthcare reform. We asked Joanne Buckle for her perspective.
Ask the tough questions. We’re ready for them.